Literature DB >> 8904443

Comparative evaluation of two serologic typing methods for hepatitis C virus.

A Cerino1, A Cividini, M Asti, A Lanza, E Silini, M U Mondelli.   

Abstract

Serologic methods of typing for hepatitis C virus offer advantages over PCR-based typing methods in terms of speed and simplicity of sample preparation and in the use of standard laboratory equipment. We examined the sensitivities and specificities of two hepatitis C virus serotyping assays which use sets of type-specific antigenic peptides derived from the core or the nonstructural 4 (NS4) regions and compared the results with those of molecular typing with type-specific primers from the core region. Although there was a good concordance between serotyping by either assay and genotyping, we found that the sensitivities of both serologic assays were less than optimal compared with that of molecular typing, with only about 50% of samples being unequivocally typed. Moreover, amino acid sequence similarities within the regions of the genome used for serotyping preclude differentiation into subtypes, which may have important clinical and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904443      PMCID: PMC228875          DOI: 10.1128/jcm.34.3.714-716.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein.

Authors:  A Machida; H Ohnuma; F Tsuda; E Munekata; T Tanaka; Y Akahane; H Okamoto; S Mishiro
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

2.  Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

Authors:  V Bhattacherjee; L E Prescott; I Pike; B Rodgers; H Bell; A R El-Zayadi; M C Kew; J Conradie; C K Lin; H Marsden
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

3.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

4.  Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

Authors:  H Okamoto; H Tokita; M Sakamoto; M Horikita; M Kojima; H Iizuka; S Mishiro
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

5.  Sequence analysis of the core gene of 14 hepatitis C virus genotypes.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

6.  Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

Authors:  L Stuyver; R Rossau; A Wyseur; M Duhamel; B Vanderborght; H Van Heuverswyn; G Maertens
Journal:  J Gen Virol       Date:  1993-06       Impact factor: 3.891

7.  Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.

Authors:  E Silini; F Bono; A Cividini; A Cerino; S Bruno; S Rossi; G Belloni; B Brugnetti; E Civardi; L Salvaneschi
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

8.  Hepatitis C virus (HCV) core serotypes in chronic HCV infection.

Authors:  M U Mondelli; A Cerino; F Bono; A Cividini; A Maccabruni; M Aricò; A Malfitano; G Barbarini; V Piazza; L Minoli
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

9.  Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates.

Authors:  J A Garson; P W Tuke; M Makris; M Briggs; S J Machin; F E Preston; R S Tedder
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

10.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

Authors:  H Okamoto; Y Sugiyama; S Okada; K Kurai; Y Akahane; Y Sugai; T Tanaka; K Sato; F Tsuda; Y Miyakawa
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

View more
  2 in total

1.  Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

Authors:  P Halfon; P Trimoulet; M Bourliere; H Khiri; V de Lédinghen; P Couzigou; J M Feryn; P Alcaraz; C Renou; H J Fleury; D Ouzan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Assessment of commercial enzyme immunoassay for hepatitis C virus serotyping.

Authors:  L M Webber; S Els; M B Taylor; W O Grabow
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.